ARTICLE | Company News
FDA approves TOBI Podhaler
March 23, 2013 12:20 AM UTC
FDA approved an NDA late Friday from Novartis AG (NYSE:NVS; SIX:NOVN) for TOBI Podhaler to manage cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. TOBI Podhaler, which uses ...